| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
11,263 |
9,565 |
$801K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
10,171 |
8,622 |
$232K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
8,455 |
5,582 |
$151K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
8,437 |
5,581 |
$95K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
24,071 |
19,712 |
$94K |
| 80050 |
General health panel |
2,730 |
1,891 |
$52K |
| 87660 |
|
3,758 |
2,746 |
$44K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
3,025 |
2,339 |
$43K |
| 87480 |
|
3,761 |
2,747 |
$43K |
| 80053 |
Comprehensive metabolic panel |
11,173 |
8,705 |
$43K |
| 84443 |
Thyroid stimulating hormone (TSH) |
6,703 |
5,043 |
$40K |
| 87653 |
|
1,607 |
1,313 |
$35K |
| 87510 |
|
3,761 |
2,747 |
$34K |
| 80061 |
Lipid panel |
6,183 |
4,362 |
$29K |
| 87806 |
|
1,825 |
1,239 |
$27K |
| 86762 |
|
2,999 |
2,269 |
$26K |
| 86803 |
|
3,066 |
2,330 |
$23K |
| 87340 |
|
4,068 |
3,005 |
$23K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
764 |
633 |
$22K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,634 |
1,191 |
$17K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
5,462 |
3,985 |
$14K |
| 84439 |
|
3,434 |
2,519 |
$13K |
| 86592 |
|
3,940 |
2,991 |
$10K |
| 84702 |
|
1,371 |
819 |
$9K |
| 82728 |
|
1,293 |
985 |
$8K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,422 |
1,935 |
$7K |
| 87081 |
|
1,607 |
1,313 |
$7K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
991 |
781 |
$6K |
| 86140 |
|
2,384 |
1,876 |
$5K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
154 |
150 |
$5K |
| 82607 |
|
837 |
615 |
$5K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
232 |
226 |
$5K |
| 85652 |
|
2,916 |
2,362 |
$4K |
| 83001 |
|
342 |
250 |
$3K |
| 83550 |
|
842 |
663 |
$3K |
| 85027 |
|
647 |
549 |
$3K |
| 83540 |
|
983 |
765 |
$3K |
| 84146 |
|
261 |
192 |
$3K |
| 82570 |
|
1,326 |
1,085 |
$2K |
| 84550 |
|
946 |
721 |
$2K |
| 82565 |
|
917 |
759 |
$2K |
| 82043 |
|
1,100 |
896 |
$2K |
| 81001 |
|
1,474 |
1,126 |
$2K |
| 85007 |
|
640 |
547 |
$2K |
| 83615 |
|
508 |
376 |
$1K |
| 84156 |
|
633 |
506 |
$1K |
| 83002 |
|
106 |
75 |
$1K |
| 80076 |
|
224 |
180 |
$822.04 |
| 87186 |
|
107 |
87 |
$580.58 |
| 83735 |
|
235 |
190 |
$556.48 |
| 82247 |
|
257 |
143 |
$521.02 |
| 84403 |
|
40 |
25 |
$492.54 |
| 82550 |
|
189 |
133 |
$472.92 |
| 84100 |
|
252 |
172 |
$380.69 |
| 86769 |
|
13 |
12 |
$379.17 |
| 81003 |
|
365 |
274 |
$315.40 |
| 82784 |
|
16 |
14 |
$214.58 |
| 82105 |
|
37 |
25 |
$167.88 |
| 87070 |
|
25 |
15 |
$139.09 |
| 82248 |
|
48 |
41 |
$124.78 |
| 87088 |
|
16 |
12 |
$78.04 |
| 36415 |
Collection of venous blood by venipuncture |
79 |
34 |
$72.23 |
| 84520 |
|
36 |
27 |
$64.74 |